American Society of Hematology, Blood Advances, 16(2), p. 2115-2126, 2018
DOI: 10.1182/bloodadvances.2018022608
Full text: Download
Key Points Individual patients with Sézary syndrome contain several distinct malignant subpopulations and show marked single-cell heterogeneity. Malignant subpopulations exhibit differences in their sensitivity to treatment warranting precision therapy.